# US Kyphosis Market > US Kyphosis Market Research Report By Type (Postural Kyphosis, Scheuermann's Kyphosis, Congenital Kyphosis), By Diagnostic Test & Diseases (X-ray, Biopsy, Aspirin, Ibuprofen, Naproxen, Spinal Fusion) and By End User (Hospitals, Diagnostic Centres, Research Organizations) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 7.17% - **2024:** $ 280 Million - **2025:** $ 300.08 Million - **2035:** $ 600 Million - **Key Players:** Medtronic (US), Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), NuVasive (US), Globus Medical (US), Orthofix Medical (US), K2M Group Holdings (US) **Report ID:** MRFR/MED/17856-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-kyphosis-market-19403 --- ## Market Summary ## **US Kyphosis Market Overview** As per MRFR analysis, the US Kyphosis Market Size was estimated at 112.56 (USD Million) in 2023. The US Kyphosis Market Industry is expected to grow from 125(USD Million) in 2024 to 225 (USD Million) by 2035. The US Kyphosis Market CAGR (growth rate) is expected to be around 5.489% during the forecast period (2025 - 2035). ### **Key US Kyphosis Market Trends Highlighted** The US Kyphosis Market is experiencing notable trends influenced by demographic shifts and healthcare advancements. One significant trend is the growing prevalence of osteoporosis and spinal deformities among the aging population. As life expectancy increases, so does the incidence of bone-related issues, driving demand for effective treatment options for kyphosis. This has been encouraged by the increasing awareness of spinal health and the importance of proactive treatment measures among healthcare providers and patients alike. Key market drivers include technological advancements in surgical techniques and minimally invasive procedures, which offer patients faster recovery times and reduced hospital stays. The introduction of innovative implants and devices tailored for kyphotic corrections is also aiding in the expansion of treatment options available in the US. Additionally, there is an increase in funding and investment in research focused on spinal disorders, particularly from governmental health initiatives aimed at improving patient outcomes. Opportunities to be explored involve the expanding landscape of telehealth services, enabling patients to access specialized care from the comfort of their homes.  This has become especially relevant in the context of the COVID-19 pandemic, prompting healthcare providers to adapt to remote consultations and follow-ups for spine-related issues.As states work to improve healthcare access, there is also potential for awareness campaigns that educate the public about early signs of kyphosis and preventive strategies. In recent times, the integration of digital health technologies into treatment plans is becoming more prevalent, encouraging patient engagement and adherence to prescribed therapies. The emphasis on personalized medicine is also shaping treatment approaches, allowing for more tailored solutions based on individual patient needs, which is expected to play a vital role in the future growth of the US Kyphosis Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Kyphosis Market Drivers** ### **Aging Population Increasing Demand for Kyphosis Treatments** The United States is witnessing a significant increase in its elderly population, which is expected to grow from 52 million in 2018 to nearly 95 million by 2060, according to the Administration on Aging. As people age, the prevalence of kyphosis and other spinal deformities increases, driving the need for effective treatments and surgical interventions. Established healthcare organizations, such as the American Association of Neurological Surgeons, underline the correlation between aging and spinal deformities, motivating the US Kyphosis Market Industry to prioritize patient care.Consequently, this demographic trend is anticipated to foster growth within the US Kyphosis Market, emphasizing surgeries such as kyphoplasty and spinal fusion, as they are performed to alleviate symptoms and restore mobility in elderly patients. As a result, the rising incidence of kyphosis among older adults will likely propel market expansion and the development of innovative treatment options. ### **Advancements in Medical Technology Enhancing Treatment Options** The continuous advancements in medical technology, particularly in minimally invasive surgical techniques and imaging technologies, are significantly influencing the US Kyphosis Market Industry. Organizations such as the American College of Surgeons have reported that minimally invasive procedures reduce recovery time and postoperative pain. Recent innovations like vertebral augmentation procedures, which improve spinal stability, have also gained traction among healthcare providers.With an estimated 5-10% of spinal surgeries in the US utilizing these advanced techniques, their growth is expected to enhance patient outcomes and drive the market forward. The embrace of new technologies by US hospitals and clinics not only makes treatment more accessible but also helps in reshaping patient perceptions about surgical interventions, supporting a favorable landscape for the US Kyphosis Market. ### **Increasing Awareness About Spinal Health and Preventive Care** There's a growing emphasis on spinal health and preventive care among the American public, heavily fueled by campaigns from reputable organizations like the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Their initiatives have raised awareness about the significance of early diagnosis and management of conditions like kyphosis, especially among at-risk groups. As per their reports, the prevalence of spinal disorders is projected to rise by 10% over the next decade, indicating a pressing need for effective awareness programs.Increased public awareness leads to more individuals seeking diagnostic services and treatment options, thereby solidifying a supportive environment for growth in the US Kyphosis Market. Enhanced knowledge about kyphosis prevention through healthy lifestyle choices and regular medical check-ups is facilitating early intervention, which can reduce the impact of this condition on quality of life. ## **US Kyphosis Market Segment Insights** ### **Kyphosis Market Type Insights** The US Kyphosis Market, primarily categorized by Type, showcases essential insights that significantly contribute to understanding the dynamics of this evolving sector. Within this market, Postural Kyphosis, Scheuermann's Kyphosis, and Congenital Kyphosis present differentiated characteristics that influence treatment approaches and market demands. Postural Kyphosis is often associated with poor posture and is increasingly prevalent among the younger population due to extensive screen time and sedentary lifestyles. This segment highlights the importance of early intervention and awareness initiatives to educate individuals on maintaining proper posture to avoid long-term complications.  On the other hand, Scheuermann's Kyphosis is characterized by a more pronounced structural deformity during adolescence and can lead to chronic pain and functional limitations if not addressed adequately. This segment is significant as it targets a demographic that requires specific surgical or non-surgical treatment options to manage the condition effectively. Given the rising cases among teens, healthcare providers are focusing on developing advanced therapeutic solutions to improve patient outcomes. Lastly, Congenital Kyphosis, resulting from spinal deformities that develop during fetal growth, often necessitates specialized care and management due to its complexity and potential impacts on overall health. As awareness regarding congenital disorders increases, the demand for tailored treatment plans and early diagnostic tools in this segment is becoming more pronounced.  The growing recognition of these different types of kyphosis reflects the broader trends in the US Kyphosis Market, emphasizing the need for targeted care strategies alongside a robust education outreach. Moreover, increased healthcare spending and advancements in medical technology are enhancing treatment methods across all types, driving market growth. Understanding the distinctions among these categories is crucial for stakeholders looking to navigate the US Kyphosis Market effectively, ensuring that they address both the immediate and long-term needs of patients across various demographics. Overall, the diverse Type segment in this market indicates significant opportunities for innovation and improvement in the quality of life for individuals affected by kyphosis. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Kyphosis Market Diagnostic Test & Diseases Insights** The Diagnostic Test and Diseases segment of the US Kyphosis Market plays a crucial role in the early identification and management of this spinal condition. This segment features a variety of essential practices, including X-ray, Biopsy, and various medications such as Aspirin, Ibuprofen, and Naproxen. X-ray imaging stands out as a primary diagnostic tool since it provides valuable insights into spinal alignment and curvature, allowing healthcare providers to assess the severity of kyphosis accurately. Additionally, Skin Biopsy procedures may occasionally be employed to investigate underlying causes related to bone health, particularly in cases suspected of malignancy.The use of non-steroidal anti-inflammatory drugs (NSAIDs) like Aspirin, Ibuprofen, and Naproxen is significant among patients who experience pain associated with kyphosis, as they offer relief and improve overall patient comfort. Furthermore, Spinal Fusion emerges as a prominent surgical option for severe cases, addressing not only pain but also restoring form and function to the spine. The increasing prevalence of osteoporosis in the aging US population is likely to further enhance the importance of these diagnostic tests and treatment options, leading to sustained growth in the market's offerings and advancements in patient care. ### **Kyphosis Market End User Insights** The US Kyphosis Market segment focusing on End Users is pivotal in shaping the overall landscape of the industry. Hospitals represent a significant portion of this segment due to their critical role in patient care, offering specialized treatments and surgical interventions for kyphosis. Diagnostic Centres are increasingly becoming essential as they provide advanced imaging and diagnostic capabilities, enabling timely detection and management of kyphosis, thereby improving patient outcomes. Research Organizations play a vital role in exploring innovative treatment methodologies and conducting clinical studies aimed at understanding the causes and long-term effects of kyphosis.The increasing prevalence of age-related conditions and the rising awareness regarding spinal health are driving demand in these areas. Additionally, government health initiatives aimed at improving orthopedic health also contribute to growth in this segment. As the medical community focuses on delivering better patient care, the collaborative efforts between these End Users will further enhance the US Kyphosis Market dynamics and ensure advancements in treatment options for this condition. ## **US Kyphosis Market Key Players and Competitive Insights** The US Kyphosis Market is experiencing a dynamic shift as advancements in healthcare technology and increasing prevalence of spinal disorders contribute to competitive activity in the sector. The market is influenced by various factors, including an aging population, rising awareness about spinal health, and innovative treatment options. Key players are focusing on research and development, product launches, and strategic collaborations to enhance their market share. The competitive landscape is characterized by a range of companies that are striving to offer superior products and services, leading to an ever-evolving environment that prioritizes patient care and outcomes. Companies are leveraging technological innovations in surgical techniques and minimally invasive procedures to gain a competitive edge and meet the growing demands of healthcare professionals and patients alike. Globus Medical is a formidable player in the US Kyphosis Market, showcasing its strengths through cutting-edge product offerings and a strong commitment to addressing spinal deformities. The company's focus on innovation is reflected in its development of advanced spinal implants and surgical instruments, which cater to the specific needs of patients experiencing kyphosis. Globus Medical has established a significant presence in the market by not only delivering effective surgical solutions but also by investing in educational programs that enhance the skillsets of healthcare providers in spinal surgery. This combination of innovative product development and comprehensive educational initiatives has significantly bolstered Globus Medical's reputation as a leader in the US Kyphosis Market, enabling it to stand out amidst competition. B. Braun also plays a crucial role in the US Kyphosis Market through its extensive range of surgical products and services that address the needs of patients with spinal deformities. The company is known for its commitment to providing high-quality medical devices, which include products designed specifically for spinal surgery. B. Braun's strengths lie in its innovative approach to designing surgical instruments and its focus on enhancing patient outcomes. The company has built a strong market presence in the US through strategic mergers and acquisitions, which have expanded its portfolio and offered new solutions for healthcare providers. B. Braun's dedication to research and development, along with its partnerships with healthcare professionals, positions it as a significant contributor to the market, equipping surgeons with the tools necessary for successful kyphosis treatments while continuing to innovate and adapt to the evolving needs of the healthcare landscape. ### **Key Companies in the US Kyphosis Market Include** ### **US Kyphosis Market Industry Developments** Recent developments in the US Kyphosis Market have seen noteworthy activity, particularly with the increasing focus on advanced treatment solutions for spinal deformities. In March 2023, Globus Medical announced advancements in its spinal fusion technologies, aimed at improving surgical outcomes for kyphosis patients. Meanwhile, Medtronic unveiled a new range of vertebral compression fracture devices in January 2023, which are expected to enhance minimally invasive procedures. Growth factors are also evident, as Stryker’s recent financial reports showcased a significant increase in revenue attributed to the rising demand for kyphosis treatments. Regarding mergers and acquisitions, DePuy Synthes completed a strategic acquisition of a spinal device company in February 2023, strengthening its position in the US market. Furthermore, TST Medical’s partnership with major healthcare institutions announced in April 2023 is poised to expand access to kyphosis care. The ongoing enhancements in technologies and surgical methods reflect a market poised for substantial growth, driven by a growing aging population and increasing awareness about spinal health. In recent years, Orthofix has also expanded its product offerings, catering to the evolving needs of patients and healthcare providers alike. ## **US Kyphosis Market Segmentation Insights** ### **Kyphosis Market Type Outlook** ### **Kyphosis Market Diagnostic Test & Diseases Outlook** ### **Kyphosis Market End User Outlook** ## Market Drivers ### Rising Healthcare Expenditure In the US, healthcare expenditure has been on an upward trajectory, which directly influences the kyphosis market. With healthcare spending projected to reach $6 trillion by 2027, there is an increasing allocation of resources towards spinal health and related treatments. This financial commitment allows for the development and implementation of advanced treatment modalities, including surgical interventions and rehabilitation programs. As patients and healthcare systems invest more in managing spinal conditions, the kyphosis market is poised for growth. The emphasis on improving patient outcomes and reducing long-term healthcare costs further drives the demand for effective kyphosis management solutions. ### Advancements in Diagnostic Techniques Recent advancements in diagnostic techniques are transforming the landscape of the kyphosis market. Enhanced imaging technologies, such as MRI and CT scans, allow for more accurate assessments of spinal conditions. These innovations facilitate early detection and intervention, which are crucial for effective management of kyphosis. The ability to diagnose spinal deformities at earlier stages is likely to lead to increased treatment rates, as patients become more aware of their conditions. Furthermore, the integration of artificial intelligence in diagnostic processes may streamline patient evaluations, potentially increasing the efficiency of care delivery in the kyphosis market. ### Aging Population and Increased Incidence The aging population in the US is a primary driver of the kyphosis market. As individuals age, the likelihood of developing spinal deformities, including kyphosis, increases significantly. Data indicates that approximately 20% of older adults experience some form of spinal deformity, which can lead to chronic pain and reduced quality of life. This demographic shift is expected to continue, with projections suggesting that by 2030, nearly 20% of the US population will be over 65 years old. Consequently, the demand for effective treatment options and management strategies within the kyphosis market is likely to rise, prompting healthcare providers to focus on innovative solutions to address this growing concern. ### Increased Focus on Rehabilitation Services The growing emphasis on rehabilitation services in the US healthcare system is a significant driver for the kyphosis market. Rehabilitation programs tailored for individuals with spinal deformities are becoming more prevalent, as they are essential for improving mobility and quality of life. The market for physical therapy and rehabilitation services is expected to expand, with estimates suggesting a growth rate of around 7% annually. This trend indicates a shift towards comprehensive care that includes not only surgical options but also non-invasive treatments. As healthcare providers recognize the importance of rehabilitation in managing kyphosis, the market is likely to see an increase in demand for specialized services. ### Growing Demand for Non-Surgical Treatment Options The rising demand for non-surgical treatment options is a notable driver in the kyphosis market. Patients are increasingly seeking alternatives to invasive procedures due to concerns about recovery times and potential complications. Non-surgical interventions, such as bracing and physical therapy, are gaining traction as effective management strategies for kyphosis. Market analysis suggests that the non-surgical segment could account for a substantial share of the overall market, driven by patient preferences and the desire for less invasive solutions. This trend reflects a broader shift in healthcare towards personalized and patient-centered care, which is likely to shape the future of the kyphosis market. ## Future Outlook The [Kyphosis Market](https://www.marketresearchfuture.com/reports/kyphosis-market-1760) is projected to grow at a 7.17% CAGR from 2025 to 2035, driven by increasing awareness, technological advancements, and rising geriatric populations. **New opportunities:** - Development of advanced spinal braces utilizing smart technology. Expansion of telehealth services for remote patient monitoring. Investment in targeted marketing campaigns for preventive care solutions. By 2035, the kyphosis market is expected to achieve substantial growth, driven by innovation and strategic initiatives. ## Segment Insights ### By Type: Postural Kyphosis (Largest) vs. Congenital Kyphosis (Fastest-Growing) In the US kyphosis market, Postural Kyphosis holds the largest share among the segment values, significantly outpacing both Scheuermann's and Congenital Kyphosis. This form primarily affects adolescents and adults with poor posture habits, leading to its widespread prevalence. Meanwhile, Congenital Kyphosis, though smaller in market share, is rapidly gaining attention due to increasing awareness and diagnosis in newborns and children, highlighting the varying focuses within this market segment. Growth trends reveal that while Postural Kyphosis remains a common issue, advancements in awareness, screening, and educational initiatives for young populations are driving the rise of Congenital Kyphosis cases. As the healthcare landscape continues to evolve, the need for targeted treatment options and improved management strategies for all kyphosis types become critical. Moreover, public health campaigns focusing on posture correction could further influence the dynamics of this segment, reinforcing existing trends. Postural Kyphosis (Dominant) vs. Congenital Kyphosis (Emerging) Postural Kyphosis is characterized by an exaggerated curvature of the spine due to poor posture, primarily affecting adults and adolescents. Its dominance in the market stems from the prevalence of lifestyle-related back issues, making it a key area for healthcare providers. On the other hand, Congenital Kyphosis, which results from spinal deformities present at birth, is emerging as a significant concern as medical advancements allow for better diagnosis and management. The increasing incidence of Congenital Kyphosis, paired with enhanced awareness among parents and pediatricians, is positioning this segment for growth. Both segments highlight the importance of targeted interventions and educational programs to address their unique challenges effectively. ### By Diagnostic Test: Imaging (Largest) vs. Biopsy (Fastest-Growing) In the US kyphosis market, the diagnostic test segment showcases a diverse distribution among its values, primarily characterized by imaging, biopsy, and others. Imaging remains the largest contributor, holding a significant market share, thanks to its reliability and non-invasive nature. The biopsy segment, while smaller, is anticipated to grow rapidly in prominence as advancements in minimally invasive techniques and precision medicine continue to gain traction among healthcare providers. Growth trends for the diagnostic test segment are influenced by several factors, including rising awareness of kyphosis conditions and an aging population that demands better diagnostic services. The efficiency of imaging tests contributes to their sustained dominance, while the emerging biopsy techniques drive interest in more accurate and timely diagnoses. As technology progresses, the balance within this segment may shift, emphasizing the need for ongoing innovation and adaptation in diagnostics. Imaging (Dominant) vs. Biopsy (Emerging) Imaging stands as the dominant diagnostic modality within the US kyphosis market, favored for its non-invasive characteristics and comprehensive visualization of spinal structures. Techniques such as X-rays, MRI, and CT scans are pivotal in identifying anatomical changes associated with kyphosis. In contrast, biopsy represents an emerging trend that focuses on acquiring tissue samples for histopathological analysis. Although currently less prevalent, biopsies are gaining traction due to their potential for delivering precise diagnoses, especially in distinguishing between different types of spinal deformities. The ongoing advancements in imaging technology and biopsy methodologies are shaping a dynamic landscape, where both segments are crucial for enhancing patient care. ### By Treatment: Surgery (Largest) vs. Medications (Fastest-Growing) In the US kyphosis market, the treatment segment showcases a diverse landscape dominated by surgery, accounting for a significant share of market activity. Surgical interventions are preferred for their ability to provide immediate relief and correct spinal deformities in advanced kyphosis cases. Meanwhile, medications, including analgesics and anti-inflammatory drugs, are gaining traction, particularly among patients seeking non-invasive options, thus contributing to a changing market dynamic. The growth trends within this segment indicate a shift towards minimally invasive procedures and personalized medication regimens, driven by technological advancements and increasing awareness. As the population ages and incidences of bone diseases rise, the demand for effective kyphosis treatments is expected to soar. Additionally, insurance policies increasingly covering these treatments further enhance their accessibility and attractiveness to patients, fueling the shift towards medications as a viable alternative for many. Surgery: Dominant vs. Medications: Emerging Surgery remains the dominant modality in the treatment of kyphosis, providing patients with substantial corrective benefits and relief from debilitating symptoms. Surgical options vary from vertebroplasty to spinal fusion, catering to a range of severity and patient conditions. This segment's strength lies in its established success rates and the backing of orthopedic expertise. In contrast, medications represent an emerging segment, gaining popularity particularly among early-stage kyphosis patients who prefer non-surgical interventions. This category includes analgesics and other therapeutic agents that aim to alleviate pain and improve quality of life. The growing trend towards self-management and non-invasive solutions positions medications as an appealing alternative to traditional surgical options, creating a more segmented approach to treat kyphosis. ### By End-User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the US kyphosis market, hospitals hold the largest share among end-users, reflecting their capacity to handle complex cases and provide comprehensive care. Clinics and ambulatory surgical centers follow, with the latter gaining traction due to the rising preference for outpatient procedures, which offer cost-effective and efficient treatment options. Growth trends for the end-user segment indicate a noticeable shift towards ambulatory surgical centers, driven by advancements in minimally invasive surgical techniques and increasing patient demand for quicker recovery times. The expansion of outpatient care facilities is expected to propel this segment further, making it the fastest-growing, as more patients opt for surgeries that allow them to return home the same day, reducing the burden on hospitals. Hospitals (Dominant) vs. Clinics (Emerging) Hospitals remain the dominant end-user in the US kyphosis market due to their ability to provide specialized and comprehensive treatment options for severe cases of kyphosis. They are equipped with advanced technology and a skilled workforce capable of managing complex and high-risk surgeries. Conversely, clinics are emerging as a significant segment, offering less invasive treatment alternatives and follow-up care. These facilities appeal to a broader patient base seeking convenience and reduced medical costs. The growth of clinics is partly fueled by an increase in awareness and diagnosis of kyphosis, allowing patients to access care more readily without the need for hospitalization. ## Competitive Benchmarking The kyphosis market exhibits a competitive landscape characterized by a blend of innovation, strategic partnerships, and regional expansion. Key players such as Medtronic (US), Stryker (US), and DePuy Synthes (US) are at the forefront, leveraging their extensive portfolios and technological advancements to capture market share. Medtronic (US) focuses on enhancing its product offerings through continuous innovation, particularly in minimally invasive surgical techniques, which aligns with the growing demand for less invasive treatment options. Stryker (US) emphasizes strategic acquisitions to bolster its capabilities, while DePuy Synthes (US) is concentrating on developing advanced spinal implants that cater to the evolving needs of healthcare providers and patients alike. Collectively, these strategies foster a dynamic competitive environment, driving growth and enhancing patient outcomes.In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach not only enhances operational efficiency but also allows for better responsiveness to market demands. The competitive structure of the kyphosis market appears moderately fragmented, with several key players influencing market dynamics. The collective actions of these companies suggest a trend towards consolidation, as they seek to leverage synergies and enhance their market positions. In October Medtronic (US) announced the launch of a new spinal fusion device designed to improve surgical outcomes and reduce recovery times. This strategic move underscores Medtronic's commitment to innovation and positions the company to meet the rising demand for advanced spinal solutions. The introduction of this device is likely to strengthen Medtronic's competitive edge in the kyphosis market, as it addresses critical pain points for both surgeons and patients. In September Stryker (US) completed the acquisition of a leading spinal technology firm, which is expected to enhance its product portfolio and expand its market reach. This acquisition reflects Stryker's strategy to integrate cutting-edge technologies into its offerings, thereby improving surgical efficiency and patient care. The move is anticipated to bolster Stryker's position in the kyphosis market, allowing it to compete more effectively against other major players. In August DePuy Synthes (US) launched a comprehensive training program for surgeons focusing on the latest advancements in kyphosis treatment techniques. This initiative not only demonstrates DePuy Synthes's commitment to education and training but also positions the company as a thought leader in the market. By equipping healthcare professionals with the necessary skills and knowledge, DePuy Synthes aims to enhance the overall quality of care in the kyphosis treatment landscape. As of November the kyphosis market is increasingly defined by trends such as digitalization, sustainability, and the integration of artificial intelligence (AI) into surgical practices. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. Looking ahead, it appears that competitive differentiation will increasingly hinge on technological advancements and supply chain reliability, rather than solely on price. Companies that prioritize innovation and adapt to evolving market demands are likely to emerge as leaders in this dynamic environment. ## Recent News & Developments Recent developments in the US Kyphosis Market have seen noteworthy activity, particularly with the increasing focus on advanced treatment solutions for spinal deformities. In March 2023, Globus Medical announced advancements in its spinal fusion technologies, aimed at improving surgical outcomes for kyphosis patients. Meanwhile, Medtronic unveiled a new range of vertebral compression fracture devices in January 2023, which are expected to enhance minimally invasive procedures. Growth factors are also evident, as Stryker’s recent financial reports showcased a significant increase in revenue attributed to the rising demand for kyphosis treatments. Regarding mergers and acquisitions, DePuy Synthes completed a strategic acquisition of a spinal device company in February 2023, strengthening its position in the US market. Furthermore, TST Medical’s partnership with major healthcare institutions announced in April 2023 is poised to expand access to kyphosis care. The ongoing enhancements in technologies and surgical methods reflect a market poised for substantial growth, driven by a growing aging population and increasing awareness about spinal health. In recent years, Orthofix has also expanded its product offerings, catering to the evolving needs of patients and healthcare providers alike. ## Report Scope | MARKET SIZE 2024 | 280.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 300.08(USD Million) | | MARKET SIZE 2035 | 600.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.17% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Stryker (US), DePuy Synthes (US), Zimmer Biomet (US), NuVasive (US), Globus Medical (US), Orthofix Medical (US), K2M Group Holdings (US) | | Segments Covered | Type, Diagnostic Test, Treatment, End-User | | Key Market Opportunities | Advancements in minimally invasive surgical techniques enhance treatment options in the kyphosis market. | | Key Market Dynamics | Rising demand for innovative treatment options drives competition and technological advancements in the kyphosis market. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the current valuation of the US kyphosis market in 2024?** A: The overall market valuation was $280.0 Million in 2024. **Q: What is the projected market valuation for the US kyphosis market by 2035?** A: The projected valuation for 2035 is $600.0 Million. **Q: What is the expected CAGR for the US kyphosis market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during the forecast period 2025 - 2035 is 7.17%. **Q: Which companies are the key players in the US kyphosis market?** A: Key players include Medtronic, Stryker, DePuy Synthes, Zimmer Biomet, NuVasive, Globus Medical, Orthofix Medical, and K2M Group Holdings. **Q: What are the market segments for the US kyphosis market?** A: The market segments include Type, Diagnostic Test, Treatment, and End-User. **Q: What was the valuation for Postural Kyphosis in 2024?** A: The valuation for Postural Kyphosis was $100.0 Million in 2024. **Q: How much is the Surgery segment projected to be worth by 2035?** A: The Surgery segment is projected to be worth between $150.0 Million and $350.0 Million by 2035. **Q: What is the valuation range for Imaging in the Diagnostic Test segment?** A: The valuation range for Imaging in the Diagnostic Test segment is between $140.0 Million and $300.0 Million. **Q: What is the expected valuation for Hospitals as an end-user by 2035?** A: The expected valuation for Hospitals as an end-user is projected to be between $112.0 Million and $240.0 Million by 2035. **Q: What was the valuation for Congenital Kyphosis in 2024?** A: The valuation for Congenital Kyphosis was $90.0 Million in 2024. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-kyphosis-market-19403*